ABM Respiratory Care continued to promote its BiWaze airway clearance platform through a series of regional professional conferences in the U.S. during the week. The company highlighted in-person demonstrations of its BiWaze Clear and BiWaze Cough systems, targeting respiratory therapists and clinical decision makers.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
ABM outlined participation in events including the Missouri Society for Respiratory Care State Conference, the Louisiana Society for Respiratory Care Annual Meeting, the West New York Spring Symposium, and WiRES 2026 in Wisconsin. The company is positioning BiWaze for both hospital and home use, emphasizing dual blower technology, bi-directional control, and emerging clinical evidence.
Across its outreach, ABM directed clinicians unable to attend in person to online resources and demo scheduling links, indicating an integrated in-person and digital engagement strategy. This focused exposure at specialty meetings is designed to build clinician awareness, support pilot adoption, and potentially strengthen ABM’s competitive standing in airway clearance and lung health.
While no specific financial metrics or sales milestones were disclosed, the multi-state conference push underscores a commercial strategy centered on clinician-driven adoption and evidence-based positioning. If these initiatives translate into stronger sales pipelines and institutional purchasing, they could support ABM Respiratory Care’s long-term revenue growth and market presence.